RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS
DRGS
DRGS was delisted on the 6th of July, 2015.
0 hedge funds and large institutions have $0 invested in RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS in 2015 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.
100% less funds holding
Funds holding: 3 → 0 (-3)
100% less capital invested
Capital invested by funds: $382K → $0 (-$382K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$370K |
| 2 |
AIG
American International Group
New York
|
-$12K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Jane Street
New York
| – | -$370K | -6,150 | Closed |
|
|
AIG
2
American International Group
New York
| – | -$12K | -200 | Closed |
|
DRGS Hedge Fund Activity: Q3 2015 in Review
0 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS (DRGS) for Q3 2015, worth a combined $0 — down 100% from $382K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of DRGS and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Jane Street, exiting entirely with an estimated $370K sold.
- 0 institutional investors held RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS (DRGS) as of Q3 2015, down from 3 in Q2 2015.
- Funds reported $0 of RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS stock for Q3 2015, down 100% quarter-over-quarter.
- 0 funds opened new RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS positions in Q3 2015 and 3 closed out, a net change of -3 holders.
- The largest RBS GLOBAL BIG PHARMA EXCHANGE TRADED NTS seller in Q3 2015 was Jane Street, an estimated $370K sold.
Based on aggregated 13F filings for Q3 2015.